PALB2-mutated breast carcinoma

Clinical trials for PALB2-mutated breast carcinoma explained in plain language.

Never miss a new study

Get alerted when new PALB2-mutated breast carcinoma trials appear

Sign up with your email to follow new studies for PALB2-mutated breast carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a Two-Drug combo shrink BRCA-Linked breast tumors?

Disease control Recruiting now

This phase 1 trial tests whether adding the experimental antibody axatilimab to the standard drug olaparib is safe and tolerable for people with HER2-negative breast cancer that has spread and is linked to BRCA1, BRCA2, or PALB2 gene changes. Researchers will enroll about 20 part…

Matched conditions: PALB2-MUTATED BREAST CARCINOMA

Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

PALB2-mutated breast carcinoma

Get alerted when new PALB2-mutated breast carcinoma trials appear

Can a Two-Drug combo shrink BRCA-Linked breast tumors?